Mucosal Vaccination against Serogroup B Meningococci: Induction of Bactericidal Antibodies and Cellular Immunity following Intranasal Immunization with NadA of Neisseria meningitidis and Mutants of Escherichia coli Heat-Labile Enterotoxin

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Infection and Immunity

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.72.7.4052-4060.2004PMID 15213150PMCID PMC427466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland.

  2004cited by this paper
• Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines

  2003influential reference
• Neisseria meningitidis App, a new adhesin with autocatalytic serine protease activity

  2003cited by this paper
• Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccine

  2003cited by this paper
• Meningococcal immunology.

  2003cited by this paper
• Vaccines for the prevention of meningococcal disease in children.

  2002cited by this paper
• NadA, a Novel Vaccine Candidate of Neisseria meningitidis

  2002cited by this paper
• Antibody Avidity and Immunoglobulin G Isotype Distribution following Immunization with a Monovalent Meningococcal B Outer Membrane Vesicle Vaccine

  2002cited by this paper
• Enhancement of Protective Efficacy following Intranasal Immunization with Vaccine Plus a Nontoxic LTK63 Mutant Delivered with Nanoparticles

  2002cited by this paper
• Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

  2001cited by this paper
• Serum bactericidal activity and isotype distribution of antibodies in toddlers and schoolchildren after vaccination with RIVM hexavalent PorA vesicle vaccine.

  2001cited by this paper
• Serological Basis for Use of Meningococcal Serogroup C Conjugate Vaccines in the United Kingdom: Reevaluation of Correlates of Protection

  2001cited by this paper
• In vivo expression of Neisseria meningitidis proteins homologous to the Haemophilus influenzae Hap and Hia autotransporters.

  2001cited by this paper
• Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000.

  2001cited by this paper
• Identification and characterization of App: an immunogenic autotransporter protein of Neisseria meningitidis

  2001cited by this paper
• A common conserved amino acid motif module shared by bacterial and intercellular adhesins: bacterial adherence mimicking cell cell recognition?

  2001cited by this paper
• Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

  2001cited by this paper
• Identification and characterisation of a novel conserved outer membrane protein from Neisseria meningitidis.

  2000cited by this paper
• Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing.

  2000cited by this paper
• Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues

  2000cited by this paper
• Complete genome sequence of Neisseria meningitidis serogroup B strain MC58.

  2000cited by this paper
• Modulation of Innate and Acquired Immune Responses by Escherichia coli Heat-Labile Toxin: Distinct Pro- and Anti-Inflammatory Effects of the Nontoxic AB Complex and the Enzyme Activity1

  2000cited by this paper
• Immunogenicity of various presentation forms of PorA outer membrane protein of Neisseria meningitidis in mice.

  1999cited by this paper
• The changing epidemiology of meningococcal disease in the United States, 1992-1996.

  1999cited by this paper
• Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile.

  1999cited by this paper
• Cellular Immune Responses to Neisseria meningitidis in Children

  1999cited by this paper
• Human IgG subclass responses in relation to serum bactericidal and opsonic activities after immunization with three doses of the Norwegian serogroup B meningococcal outer membrane vesicle vaccine.

  1999cited by this paper
• Potential and limitations of polysaccharide vaccines in infancy.

  1998cited by this paper
• Meningococcal Vaccines

  1998cited by this paper
• Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity

  1998cited by this paper
• Structural determinants of processing and secretion of the Haemophilus influenzae Hap protein

  1997cited by this paper
• Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.

  1997cited by this paper
• Characterization of the genetic locus encoding Haemophilus influenzae type b surface fibrils

  1996cited by this paper
• Current Protocols in Protein Science

  1996cited by this paper
• Development of a meningococcal vaccine.

  1995cited by this paper
• Development of a meningococcal vaccine.

  1995cited by this paper
• Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines

  1995cited by this paper
• A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit

  1994cited by this paper
• Aspects of the molecular structure of IgG subclasses.

  1986cited by this paper

• Structural dynamics and immunogenicity of the recombinant and outer membrane vesicle-embedded Meningococcal antigen NadA

  2024cites this paper
• Neisserial adhesin A (NadA) binds human Siglec-5 and Siglec-14 with high affinity and promotes bacterial adhesion/invasion

  2024cites this paper
• A recombinant commensal bacteria elicits heterologous antigen-specific immune responses during pharyngeal carriage

  2021cites this paper
• Alternative vaccine delivery methods

  2020cites this paper
• Rational design of adjuvants for subunit vaccines: The format of cationic adjuvants affects the induction of antigen-specific antibody responses.

  2020cites this paper
• Immunogenicity of trimeric autotransporter adhesins and their potential as vaccine targets

  2019cites this paper
• Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia.

  2019cites this paper
• Longitudinal Evaluation of Humoral Immunity and Bacterial and Clinical Parameters Reveals That Antigen-Specific Antibodies Suppress Inflammatory Responses in Active Tuberculosis Patients

  2018cites this paper
• LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1.

  2017cites this paper
• Exploiting chimeric human antibodies to characterize a protective epitope of Neisseria adhesin A, one of the Bexsero vaccine components

  2016cites this paper
• Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology

  2016cites this paper
• B cells and antibodies in the defense against Mycobacterium tuberculosis infection

  2015cites this paper
• Role of ARF6, Rab11 and External Hsp90 in the Trafficking and Recycling of Recombinant-Soluble Neisseria meningitidis Adhesin A (rNadA) in Human Epithelial Cells

  2014cites this paper
• Characterization of an autotransporter adhesin protein shared by Burkholderia mallei and Burkholderia pseudomallei

  2014cites this paper
• Structure of the meningococcal vaccine antigen NadA and epitope mapping of a bactericidal antibody

  2014cites this paper
• The role of the NadR regulator during infection and its implication for the coverage of a new Meningococcus B vaccine

  2013cites this paper
• Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery.

  2012cites this paper
• Human heat shock protein (Hsp) 90 interferes with Neisseria meningitidis adhesin A (NadA)‐mediated adhesion and invasion

  2012cites this paper
• Membrane Protein As Novel Targets For Vaccine Production In Haemophilus Influenzae And Neisseria Meningitidis

  2012influential citation
• SadA, a Trimeric Autotransporter from Salmonella enterica Serovar Typhimurium, Can Promote Biofilm Formation and Provides Limited Protection against Infection

  2011cites this paper
• Cloning, expression and purification of outer membrane protein PorA of Neisseria meningitidis serogroup B.

  2011cites this paper
• Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines

  2011cites this paper
• Escherichia coli Heat-Labile Enterotoxin Promotes Protective Th17 Responses against Infection by Driving Innate IL-1 and IL-23 Production

  2011cites this paper
• Immunogenicity and protection against Haemophilus parasuis infection after vaccination with recombinant virulence associated trimeric autotransporters (VtaA).

  2011cites this paper
• 2 Rational design of nasal vaccines

  2011cites this paper
• Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine.

  2010cites this paper
• Virulence determinants involved in differential host niche adaptation of Neisseriameningitidis and Neisseria gonorrhoeae

  2010cites this paper
• Subunit Vaccines against Infection with Mycobacterium Tuberculosis : Preclinical and Clinical Considerations

  2010cites this paper
• Prime-Boost Immunogenicity of Class 5C Protein from Neisseria meningitidis in Mice with Different Adjuvants

  2009cites this paper
• Bacterial adhesins in host-microbe interactions.

  2009cites this paper
• Development of antigen-specific T cells in mediastinal lymph nodes after intranasal immunization.

  2009cites this paper
• Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge.

  2009cites this paper
• Expression of the meningococcal adhesin NadA is controlled by a transcriptional regulator of the MarR family

  2009cites this paper
• Challenges and progress in the development of a serogroup B meningococcal vaccine

  2009cites this paper
• Rational design of nasal vaccines

  2008cites this paper
• Transcutaneous Immunization with Cross-Reacting Material CRM197 of Diphtheria Toxin Boosts Functional Antibody Levels in Mice Primed Parenterally with Adsorbed Diphtheria Toxoid Vaccine

  2008cites this paper
• Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.

  2008cites this paper
• Specificity of Subcapsular Antibody Responses in Ethiopian Patients following Disease Caused by Serogroup A Meningococci

  2008cites this paper
• Mucosal vaccination against bacterial respiratory infections

  2008cites this paper
• Intranasal vaccines for protection against resipratory and systemic bacterial infections

  2007cites this paper
• Immunogenicity of meningococcal PorA antigens in OMV vaccines

  2006cites this paper
• Mechanisms of pathogenesis and prevention of meningococcal disease

  2006cites this paper
• Meningococcal diseases: From genomes to vaccines

  2006cites this paper
• Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Guérin Immunity1

  2006cites this paper
• Methodes et compositions relatives a des adhesines servant d'adjuvants

  2006cites this paper
• A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide.

  2006cites this paper
• Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.

  2006cites this paper
• Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis.

  2006cites this paper
• Serogroup B meningococcal vaccines.

  2006cites this paper
• Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.

  2006cites this paper
• Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis.

  2006cites this paper
• Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines.

  2006cites this paper
• Characterization of MspA, an Immunogenic Autotransporter Protein That Mediates Adhesion to Epithelial and Endothelial Cells in Neisseria meningitidis

  2006influential citation
• Protein secretion and secreted proteins in pathogenic Neisseriaceae.

  2006influential citation
• Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration.

  2006cites this paper
• T cells, dendritic cells and the human immune response to viruses and vaccines

  2006cites this paper
• IS1301 Fingerprint Analysis of Neisseria meningitidis Strains Belonging to the ET-15 Clone

  2006cites this paper
• Modified Bacterial Toxins

  2006cites this paper
• TB subunit vaccines--putting the pieces together.

  2005cites this paper
• Towards an improved serogroup B Neisseria meningitidis vaccine

  2005cites this paper
• Generation of improved mucosal vaccines by induction of innate immunity

  2005cites this paper
• Microsatellite instability regulates transcription factor binding and gene expression.

  2005cites this paper
• Induction of Protective Serum Meningococcal Bactericidal and Diphtheria-Neutralizing Antibodies and Mucosal Immunoglobulin A in Volunteers by Nasal Insufflations of the Neisseria meningitidis Serogroup C Polysaccharide-CRM197 Conjugate Vaccine Mixed with Chitosan

  2005cites this paper